NLS Pharmaceutics Ltd. ("NLS") (Nasdaq: NLSP), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for rare and complex central nervous ...
Patients with ERBB2-positive breast cancer and CNS-only metastasis are at a high risk for CNS-related death but have longer overall survival than those with concomitant extracranial metastases.
A groundbreaking study suggests that IBS might be more of a brain issue than a gut disorder. Researchers found that stress-induced IBS symptoms could be alleviated by drugs that regulate ...